A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -8.30%), Recursion Pharmaceuticals ( RXRX -3.98%), and CRISPR Therapeutics ( CRSP -1.49%), plunged in March, with the stocks down 35.3%, ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and champio ...

By Maggie Fick and Bhanvi Satija LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers ...

New Wave Biotech and Nurasa have partnered to publish a new whitepaper exploring how lean startup principles --- originally ...

Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and ...